BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 26590176)

  • 1. Cardiac mesenchymal stromal cells are a source of adipocytes in arrhythmogenic cardiomyopathy.
    Sommariva E; Brambilla S; Carbucicchio C; Gambini E; Meraviglia V; Dello Russo A; Farina FM; Casella M; Catto V; Pontone G; Chiesa M; Stadiotti I; Cogliati E; Paolin A; Ouali Alami N; Preziuso C; d'Amati G; Colombo GI; Rossini A; Capogrossi MC; Tondo C; Pompilio G
    Eur Heart J; 2016 Jun; 37(23):1835-46. PubMed ID: 26590176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophilin A in Arrhythmogenic Cardiomyopathy Cardiac Remodeling.
    Rurali E; Pilato CA; Perrucci GL; Scopece A; Stadiotti I; Moschetta D; Casella M; Cogliati E; Sommariva E; Pompilio G; Nigro P
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excess TGF-β1 Drives Cardiac Mesenchymal Stromal Cells to a Pro-Fibrotic Commitment in Arrhythmogenic Cardiomyopathy.
    Maione AS; Stadiotti I; Pilato CA; Perrucci GL; Saverio V; Catto V; Vettor G; Casella M; Guarino A; Polvani G; Pompilio G; Sommariva E
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca
    Maione AS; Faris P; Iengo L; Catto V; Bisonni L; Lodola F; Negri S; Casella M; Guarino A; Polvani G; Cerrone M; Tondo C; Pompilio G; Sommariva E; Moccia F
    J Transl Med; 2022 Nov; 20(1):522. PubMed ID: 36371290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy.
    Lombardi R; Dong J; Rodriguez G; Bell A; Leung TK; Schwartz RJ; Willerson JT; Brugada R; Marian AJ
    Circ Res; 2009 May; 104(9):1076-84. PubMed ID: 19359597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [THE EFFECT OF PLAKOPHILIN-2 GENE MUTATIONS ON ACTIVITY OF THE CANONICAL Wnt SIGNALING PATHWAY].
    Khudiakov AA; Kostina DA; Kostareva AA; Tomilin AN; Malashicheva AB
    Tsitologiia; 2015; 57(12):868-75. PubMed ID: 26995964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients.
    Pilato CA; Stadiotti I; Maione AS; Saverio V; Catto V; Tundo F; Dello Russo A; Tondo C; Pompilio G; Casella M; Sommariva E
    J Vis Exp; 2018 Feb; (132):. PubMed ID: 29553539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
    Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
    Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic lineage tracing identifies cardiac mesenchymal-to-adipose transition in an arrhythmogenic cardiomyopathy model.
    Huang X; Yan L; Meng J; Liu N; Zhu S; Jiang Z; Kou S; Feng T; Lin CP; Zhou B; Tang J; Zhu P; Zhang H
    Sci China Life Sci; 2023 Jan; 66(1):51-66. PubMed ID: 36322324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear plakoglobin is essential for differentiation of cardiac progenitor cells to adipocytes in arrhythmogenic right ventricular cardiomyopathy.
    Lombardi R; da Graca Cabreira-Hansen M; Bell A; Fromm RR; Willerson JT; Marian AJ
    Circ Res; 2011 Dec; 109(12):1342-53. PubMed ID: 22021931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Store-Operated Ca
    Moccia F; Brunetti V; Soda T; Faris P; Scarpellino G; Berra-Romani R
    J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
    Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
    Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular disturbance underlies to arrhythmogenic cardiomyopathy induced by transgene content, age and exercise in a truncated PKP2 mouse model.
    Moncayo-Arlandi J; Guasch E; Sanz-de la Garza M; Casado M; Garcia NA; Mont L; Sitges M; Knöll R; Buyandelger B; Campuzano O; Diez-Juan A; Brugada R
    Hum Mol Genet; 2016 Sep; 25(17):3676-3688. PubMed ID: 27412010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrhythmogenic Cardiomyopathy: the Guilty Party in Adipogenesis.
    Stadiotti I; Catto V; Casella M; Tondo C; Pompilio G; Sommariva E
    J Cardiovasc Transl Res; 2017 Dec; 10(5-6):446-454. PubMed ID: 28983804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive Reduction in Right Ventricular Contractile Function Attributable to Altered Actin Expression in an Aging Mouse Model of Arrhythmogenic Cardiomyopathy.
    Camors EM; Roth AH; Alef JR; Sullivan RD; Johnson JN; Purevjav E; Towbin JA
    Circulation; 2022 May; 145(21):1609-1624. PubMed ID: 35437032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy.
    Garcia-Gras E; Lombardi R; Giocondo MJ; Willerson JT; Schneider MD; Khoury DS; Marian AJ
    J Clin Invest; 2006 Jul; 116(7):2012-21. PubMed ID: 16823493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GCN5 contributes to intracellular lipid accumulation in human primary cardiac stromal cells from patients affected by Arrhythmogenic cardiomyopathy.
    Volani C; Pagliaro A; Rainer J; Paglia G; Porro B; Stadiotti I; Foco L; Cogliati E; Paolin A; Lagrasta C; Frati C; Corradini E; Falco A; Matzinger T; Picard A; Ermon B; Piazza S; De Bortoli M; Tondo C; Philippe R; Medici A; Lavdas AA; Blumer MJF; Pompilio G; Sommariva E; Pramstaller PP; Troppmair J; Meraviglia V; Rossini A
    J Cell Mol Med; 2022 Jul; 26(13):3687-3701. PubMed ID: 35712781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truncating plakophilin-2 mutations in arrhythmogenic cardiomyopathy are associated with protein haploinsufficiency in both myocardium and epidermis.
    Rasmussen TB; Nissen PH; Palmfeldt J; Gehmlich K; Dalager S; Jensen UB; Kim WY; Heickendorff L; Mølgaard H; Jensen HK; Baandrup UT; Bross P; Mogensen J
    Circ Cardiovasc Genet; 2014 Jun; 7(3):230-40. PubMed ID: 24704780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of two edited iPSCs lines by CRISPR/Cas9 with point mutations in PKP2 gene for arrhythmogenic cardiomyopathy in vitro modeling.
    Amin G; Castañeda SL; Zabalegui F; Belli C; Atorrasagasti C; Miriuka SG; Moro LN
    Stem Cell Res; 2023 Sep; 71():103157. PubMed ID: 37393721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing the Molecular Pathology of Arrhythmogenic Cardiomyopathy in Patient Buccal Mucosa Cells.
    Asimaki A; Protonotarios A; James CA; Chelko SP; Tichnell C; Murray B; Tsatsopoulou A; Anastasakis A; te Riele A; Kléber AG; Judge DP; Calkins H; Saffitz JE
    Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003688. PubMed ID: 26850880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.